Insulin-like growth factor-1 and lipoprotein profile in cord blood of preterm small for gestational age infants

N Nagano1, T Okada1, R Fukamachi1

  • 11 Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.

Insights

Insulin-like growth factor-1 (IGF-1) levels in preterm infants are linked to cord blood lipid profiles. Lower IGF-1 in small for gestational age (SGA) infants correlates with altered lipid levels, impacting future cardiometabolic health.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Cardiovascular Science

Background:

  • Low birth weight is a risk factor for adult cardiometabolic diseases.
  • Insulin-like growth factor-1 (IGF-1) influences fetal growth and adult cardiometabolic risk.

Purpose of the Study:

  • To investigate the association between IGF-1 levels and serum lipids in the cord blood of preterm infants.
  • To compare lipid profiles and IGF-1 levels between small for gestational age (SGA) and appropriate for gestational age (AGA) preterm neonates.

Main Methods:

  • Analyzed cord blood from 41 healthy preterm neonates (<37 weeks gestational age), including 10 SGA infants.
  • Measured IGF-1 levels and serum lipids (total cholesterol, LDLC, HDLC, VLDLTG) using HPLC.
  • Performed simple and multiple regression analyses to determine correlations and independent predictors.

Main Results:

  • SGA infants exhibited lower IGF-1, total cholesterol, LDLC, and HDLC, with higher VLDLTG compared to AGA infants.
  • IGF-1 positively correlated with birth weight, total cholesterol, LDLC, and HDLC, and negatively with triglycerides and VLDL-TG.
  • IGF-1 independently predicted total cholesterol, HDLC, and triglyceride levels, adjusting for gestational age and birth weight.

Conclusions:

  • Cord blood lipid profiles are altered in preterm SGA infants, associated with decreased IGF-1 levels.
  • IGF-1 is a significant predictor of lipid profiles in preterm neonates, suggesting a role in early cardiometabolic programming.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
548
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K